Search - tctmd.com

Displaying 41 - 60 of 103

Sort: Relevancy | Date

Presentation NY Valves 2025

Is There Hope for Medical Management of Aortic Stenosis? New Potential Therapies for Prevention and Treatment

Presenter: Brian R. Lindman

June 25, 2025

Presentation NY Valves 2025

Electronic Provider Notification Mitigates Sex Disparities in the Treatment of Severe Aortic Stenosis: Insights From the DETECT AS Trial

Presenter: Sammy Elmariah

June 25, 2025

Presentation NY Valves 2025

Guideline Directed Indications and Consequences of Delayed AVR in Patients With Asymptomatic, Severe Aortic Stenosis: Results From the EARLY TAVR Trial

Presenter: Allan Schwartz

June 25, 2025

Presentation NY Valves 2025

Case Resolution

Presenter: Robin Le Ruz

June 25, 2025

Presentation NY Valves 2025

Can We Solve the Durability Issue? Insights Into New Valve Designs

Presenter: Tamim M. Nazif

June 25, 2025

Presentation NY Valves 2025

Considerations for TAVR-First or SAVR-First Strategies in Young Patients

Presenter: Mayra Guerrero

June 25, 2025

Presentation NY Valves 2025

Balloon Aortic Valvuloplasty for Severe Aortic Stenosis in Late Second-Trimester Pregnancy

Presenter: Samuel Moore

June 25, 2025

Presentation NY Valves 2025

PRO – SURGERY: 3 Reasons Why Surgery Is the Best Option for This Patient

Presenter: Christine J. Chung

June 25, 2025

Presentation NY Valves 2025

PRO – TAVR: 3 Reasons Why TAVR Is the Best Option for This Patient

Presenter: Isaac George

June 25, 2025

Presentation NY Valves 2025

Transcatheter Aortic Valve Replacement in Concomitant Severe Aortic Stenosis and Hypertrophic Obstructive Cardiomyopathy: Effects of Acute Afterload and Preload Changes

Presenter: Abhishek Kumar

June 25, 2025

Presentation NY Valves 2025

Case Presentation: A Young Low-Risk Patient With Symptomatic Severe Tri-Leaflet Aortic Stenosis

Presenter: Robin Le Ruz

June 25, 2025

Presentation NY Valves 2025

Rationale and Status of “At Risk” Moderate AS Trials (PROGRESS and EXPAND TAVR II)

Presenter: Raj Makkar

June 25, 2025

Presentation NY Valves 2025

Perspectives From TAVR UNLOAD

Presenter: Nicolas M. Van Mieghem

June 25, 2025

Presentation NY Valves 2025

Do We Need Advanced Imaging to Phenotype Asymptomatic AS Patients? Lessons From the EVOLVED Trial

Presenter: Marc R. Dweck

June 25, 2025

Presentation NY Valves 2025

Not Much, We Need Stronger Evidence!

Presenter: Michael J. Mack

June 25, 2025

Presentation NY Valves 2025

Yes, Most Definitely!

Presenter: Philippe Genereux

June 25, 2025

Presentation NY Valves 2025

Managing AS Patients Before Symptoms or Severe Disease: Insights Into Current Practice

Presenter: Patrick T. O'Gara

June 25, 2025

News Conference News NY Valves 2024

Bioprosthetic Valve Dysfunction Tied to Worse Outcomes After AVR

Todd Neale

June 14, 2024

News Conference News NY Valves 2024

National Data Point to Soaring TAVI Rates in Patients Under 65

Michael O'Riordan

June 14, 2024

News Conference News NY Valves 2024

Dedicated Devices for Aortic Regurgitation Supported by Meta-analysis

Todd Neale

June 13, 2024

Advertisement

Is There Hope for Medical Management of Aortic Stenosis? New Potential Therapies for Prevention and Treatment

Electronic Provider Notification Mitigates Sex Disparities in the Treatment of Severe Aortic Stenosis: Insights From the DETECT AS Trial

Guideline Directed Indications and Consequences of Delayed AVR in Patients With Asymptomatic, Severe Aortic Stenosis: Results From the EARLY TAVR Trial

Case Resolution

Can We Solve the Durability Issue? Insights Into New Valve Designs

Considerations for TAVR-First or SAVR-First Strategies in Young Patients

Balloon Aortic Valvuloplasty for Severe Aortic Stenosis in Late Second-Trimester Pregnancy

PRO – SURGERY: 3 Reasons Why Surgery Is the Best Option for This Patient

PRO – TAVR: 3 Reasons Why TAVR Is the Best Option for This Patient

Transcatheter Aortic Valve Replacement in Concomitant Severe Aortic Stenosis and Hypertrophic Obstructive Cardiomyopathy: Effects of Acute Afterload and Preload Changes

Case Presentation: A Young Low-Risk Patient With Symptomatic Severe Tri-Leaflet Aortic Stenosis

Rationale and Status of “At Risk” Moderate AS Trials (PROGRESS and EXPAND TAVR II)

Perspectives From TAVR UNLOAD

Do We Need Advanced Imaging to Phenotype Asymptomatic AS Patients? Lessons From the EVOLVED Trial

Not Much, We Need Stronger Evidence!

Yes, Most Definitely!

Managing AS Patients Before Symptoms or Severe Disease: Insights Into Current Practice

Bioprosthetic Valve Dysfunction Tied to Worse Outcomes After AVR

National Data Point to Soaring TAVI Rates in Patients Under 65

Dedicated Devices for Aortic Regurgitation Supported by Meta-analysis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content